A Survey on Interpretability in Visual Recognition
Clinical Snapshot
PICO Framework
| P — Population | Not applicable — this is a narrative/systematic survey of explainable AI (XAI) methods applied to visual recognition models, not a clinical population study |
| I — Intervention | Explainable AI (XAI) techniques for visual recognition, including attribution methods, concept-based explanations, and multimodal large language model interpretability approaches |
| C — Comparator | No formal comparator defined; implicit comparison across XAI methodological categories and evaluation frameworks |
| O — Outcomes | Interpretability quality metrics, evaluation desiderata, qualitative and quantitative benchmarks of XAI methods across visual recognition tasks including medical diagnostics and autonomous driving |
Bottom Line
This paper is a broad narrative survey of explainable AI (XAI) methods for visual recognition systems, published in a leading computer science journal. It is not a clinical systematic review or meta-analysis, and applying the Oxford CEBM framework reveals fundamental structural limitations from an evidence-based medicine perspective: no PICO question, no systematic search, no risk of bias assessment, no patient-relevant outcomes, and no statistical synthesis. The CEBM score of 15/100 reflects this category mismatch rather than poor scholarship — the paper is technically competent within its own disciplinary norms. For senior clinicians and clinical AI governance teams, the survey's value lies in its conceptual taxonomy of XAI approaches and its identification of evaluation frameworks relevant to medical diagnostic AI. As regulators globally — including Australia's TGA — increasingly require explainability documentation for AI medical devices, understanding the landscape of available XAI methods has practical governance relevance. However, no clinical practice recommendations can be derived from this work. Clinicians evaluating AI diagnostic tools should seek primary validation studies with patient-relevant outcomes rather than relying on this survey for evidence-based adoption decisions.
Key Findings
P Value: Not applicable — no hypothesis testing performed
Effect Size: Not applicable — no pooled effect size reported
Primary Outcome: Taxonomic classification of XAI methods for visual recognition across four dimensions: intent, object, presentation, and methodology. No primary clinical outcome is defined.
Nnt Or Sensitivity: Not applicable — no NNT, sensitivity, specificity, or hazard ratio reported. Quantitative benchmarks are technical XAI performance metrics (e.g., faithfulness, localisation accuracy) without clinical interpretability
Confidence Interval: Not applicable — no confidence intervals reported
Clinical Application
The survey's findings are not directly implementable in clinical practice. They may inform procurement decisions for AI diagnostic systems, guide requirements for XAI features in clinical AI tools, or support regulatory submissions requiring model explainability documentation. Practical implementation requires translation by clinical informatics specialists. In Australia, the Therapeutic Goods Administration (TGA) regulates AI-based medical devices under the Software as a Medical Device (SaMD) framework, and the Australian Digital Health Agency (ADHA) has published guidance on responsible AI in health. This survey's taxonomy of XAI methods is conceptually relevant to TGA conformity assessment requirements for explainability and transparency in AI diagnostic tools. The RACGP has not issued specific guidelines on XAI requirements for clinical AI, but the Medical Board of Australia's guidance on AI emphasises clinician understanding of AI outputs — a domain where XAI methods surveyed here are directly relevant. PBS and TGA approval pathways for AI-assisted diagnostics (e.g., AI retinal screening, AI-assisted pathology) would benefit from the evaluation frameworks described, though direct clinical practice change cannot be recommended based on this survey alone. Not directly applicable to a defined patient population. Potentially relevant to clinical informaticists, radiologists, pathologists, and clinical AI governance teams seeking to understand the landscape of explainability methods for AI-assisted diagnostic tools
Abstract
Visual recognition models have achieved unprecedented success in various tasks. While researchers aim to understand the underlying mechanisms of these models, the growing demand for deployment in safety-critical areas like autonomous driving and medical diagnostics has accelerated the development of eXplainable AI (XAI). Distinct from generic XAI, visual recognition XAI is positioned at the intersection of vision and language, which represent the two most fundamental human modalities and form the cornerstones of multimodal intelligence. This paper provides a systematic survey of XAI in visual recognition by establishing a multi-dimensional taxonomy from a human-centered perspective based on intent, object, presentation, and methodology. Beyond categorization, we summarize critical evaluation desiderata and metrics, conducting an extensive qualitative assessment across different categories and demonstrating quantitative benchmarks within specific dimensions. Furthermore, we explore the interpretability of Multimodal Large Language Models and practical applications, identifying emerging trends and opportunities. By synthesizing these diverse perspectives, this survey provides an insightful roadmap to inspire future research on the interpretability of visual recognition models.
References
- 1.Wan, Q., Gao, C., Wang, R., & Chen, X. (2026). A survey on interpretability in visual recognition. IEEE Transactions on Pattern Analysis and Machine Intelligence. https://doi.org/10.1109/TPAMI.2026.3672629
Related Research
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Artificial Intelligence Tools for Gastrointestinal Research: A Practical Guide
2 Aug 2026
Clinical spine surgery
An Introduction to Machine Learning for the Practicing Spine Surgeon
2 Aug 2026
Rheumatic diseases clinics of North America
Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service